androfin 5mg potahovaná tableta
g.l. pharma gmbh, lannach array - 11225 finasterid - potahovaná tableta - 5mg - finasterid
gerodorm 40mg tableta
g.l. pharma gmbh, lannach array - 8915 cinolazepam - tableta - 40mg - cinolazepam
lodronat 520mg potahovaná tableta
esteve pharmaceuticals gmbh, berlín array - 14827 tetrahydrÁt dinatrium-klodronÁtu - potahovaná tableta - 520mg - kyselina klodronovÁ
salofalk 500mg Čípek
dr. falk pharma gmbh, freiburg array - 9268 mesalazin - Čípek - 500mg - mesalazin
salofalk 500mg enterosolventní tableta
dr. falk pharma gmbh, freiburg array - 9268 mesalazin - enterosolventní tableta - 500mg - mesalazin
norepinephrine hameln 0,2mg/ml infuzní roztok
hameln pharma gmbh, hameln array - 826 monohydrÁt norepinefrin-tartarÁtu - infuzní roztok - 0,2mg/ml - norepinefrin
atimos 12mcg/dáv roztok k inhalaci v tlakovém obalu
chiesi pharmaceuticals gmbh, vídeň array - 14188 dihydrÁt formoterol-fumarÁtu - roztok k inhalaci v tlakovém obalu - 12mcg/dÁv - formoterol
tetmodis 25mg tableta
aop orphan pharmaceuticals gmbh, wien array - 6116 tetrabenazin - tableta - 25mg - tetrabenazin
naltrexone aop 50mg potahovaná tableta
aop orphan pharmaceuticals gmbh, wien array - 9834 naltrexon-hydrochlorid - potahovaná tableta - 50mg - naltrexon
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - hydrochlorid klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidla - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.